Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 6/20 | 0.68 |
| ▸ | PTGS2 | P35354 | 7/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.56 |
| ▸ | CA12 | O43570 | 5/20 | 0.49 |
| ▸ | CA2 | P00918 | 5/20 | 0.49 |
| ▸ | CA9 | Q16790 | 5/20 | 0.49 |
| ▸ | CA1 | P00915 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8974637 | 0.86 | KIF11 (0.70) | KIF11PTGS2PTGS1CA12CA2 | |
| SCHEMBL8974631 | 0.86 | PTGS1 (0.53) | KIF11PTGS2PTGS1CA12CA2 | |
| SCHEMBL8974232 | 0.86 | KIF11 (0.50) | KIF11PTGS2PTGS1CA12CA2 | |
| SCHEMBL8973900 | 0.86 | KIF11 (0.50) | KIF11PTGS2PTGS1CA12CA2 | |
| SCHEMBL8973917 | 0.85 | KIF11 (0.68) | KIF11PTGS2PTGS1CA12CA2 | |
| SCHEMBL6324533 | 0.85 | PTGS2 (0.56) | KIF11PTGS2PTGS1 | |
| SCHEMBL8974160 | 0.83 | KIF11 (0.45) | KIF11PTGS2PTGS1CA12CA2 | |
| SCHEMBL8974079 | 0.82 | KIF11 (0.64) | KIF11PTGS2PTGS1CA12CA2 | |
| SCHEMBL8974579 | 0.81 | KIF11 (0.62) | KIF11PTGS2PTGS1CA12CA2 | |
| SCHEMBL8974445 | 0.81 | KIF11 (0.62) | KIF11PTGS2PTGS1CA12CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5576339-A | Pyridyl substituted cyclopentadienes for the treatment of inflamation | HUANG HORNG-CHIH (US) | 1996-11-19 | — | — | US | disclosed |
| WO-1995030656-A1 | SUBSTITUTED CYCLOPENTADIENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1995-11-16 | — | — | WO | disclosed |
| US-5418254-A | Side effect reduction | G. D. SEARLE & CO. (US) | 1995-05-23 | — | — | US | disclosed |